|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|
|||
 |
 |
Psychiatry Archives 1. Cao Y-J, Smith PF, Wire MB, Lou Y, Lancaster
CT, Causon RC, Bigelow GE, Martinez E, Fuchs EJ, Radebaugh C, McCabe S,
Hendrix CW. Pharmacokinetics and pharmacodynamics of methadone enantiomers
after coadministration with fosamprenavir-ritonavir in opioid-dependent
subjects. Pharmacotherapy 2008 Jul;28(7):863-874. 4. Hienz RD, Brady JV, Gooden VL, Vazquez ME, Weed
MR. Neurobehavioral effects of head-only gamma radiation exposure in rats.
Radiation Research 2008 Sep;170(3):292-8. 5. Neufeld K, King V, Peirce J, Kolodner K, Brooner
R, Kidorf M. A comparison of 1-year substance abuse treatment outcomes
in community syringe exchange participants versus other referrals. Drug
and Alcohol Dependence 2008 Sept; 97(1): 122-129. 1. Bello NT, Kemm MH,
Moran TH. Salmon calcitonin reduces food intake through changes in meal
sizes in male rhesus monkeys. Am J Physiol Regul Integr Comp Physiol.
2008 Jul;295(1):R76-81. 2. Burdick KE, Kamiya
A, Hodgkinson CA, Lencz T, DeRosse P, Ishizuka K, Elashvili S, Arai H,
Goldman D, Sawa A, Malhotra AK. Elucidating the relationship between DISC1,
NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and
competitive binding. Hum Mol Genet. 2008 Aug 15;17(16):2462-73. 3. Paulsen JS, Langbehn
DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, McDonald
M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden
M. Detection of Huntington's disease decades before diagnosis: The Predict
HD study. J Neurol Neurosurg Psychiatry. 2008 Aug; 79(8): 874-80. 4. Perkins KA, Lerman
C, Stitzer ML, Fonte CA, Briski JL, Scott JA, Chengappa KNR. Development
of procedures for early screening of smoking cessation medications in
humans. Clin Pharmacol Ther 2008 Aug; 79 (8): 874-80. 5. Redgrave GW, Bakker
A, Bello NT, Caffo BS, Coughlin JW, Guarda AS, McEntee JE, Pekar JJ, Reinblatt
SP, Verduzco G, Moran TH. Differential brain activation in anorexia nervosa
to Fat and Thin words during a Stroop task. Neuroreport. 2008 Aug 6;19(12):1181-5. 6. Robins CS, Ware NC,
dosReis S, Willging CE, Chung JY, Lewis- Fernández R. Dialogues
on mixed-methods mental health services research: Anticipating challenges,
building Solutions. Psychiatric Services 2008 Jul;59(7):727-31. 7. Sen N, Hara MR, Kornberg
MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder
SH, Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and
mediates apoptosis. Nat Cell Biol. 2008 Jul;10(7):866-73. 8. Weed MR, Wilcox KM,
Ator NA, Hienz RD. Consistent, high-level ethanol consumption in pig-tailed
macaques via a multiple-session, limited-intake, oral self-dosing procedure.
Alcohol Clin Exp Res. 2008 Jun;32(6):942-51. 9. Zagoory-Sharon O,
Schroeder M, Levine A, Moran TH, Weller A. Adaptation to lactation in
OLETF rats lacking CCK-1 receptors: body weight, fat tissues, leptin and
oxytocin. Int J Obes (Lond). 2008 Aug;32(8):1211-21. 10. Zandi PP, Belmonte
PL, Willour VL, Goes FS, Badner JA, Simpson SG, Gershon ES, McMahon FJ,
DePaulo JR Jr, Potash JB; Bipolar Disorder Phenome Group; National Institute
of Mental Health Genetics Initiative Bipolar Disorder Consortium. Association
study of Wnt signaling pathway genes in bipolar disorder. Arch Gen Psychiatry.
2008 Jul;65(7):785-93. 1. Grados MA, Vasa RA, Riddle MA, Slomine BS, Salorio
C, Christensen J, Gerring J. New onset obsessive-compulsive symptoms in
children and adolescents with severe traumatic brain injury. Depress Anxiety
2008 May; 25(5):398-407. 2. Lyketsos CG, Szekely CA, Mielke MM, Rosenberg
PB, Zandi PP. Developing new treatments for Alzheimer's disease: the who,
what, when, and how of biomarker-guided therapies. Int Psychogeriatr.
2008 May 23:1-19. 3. MacKinnon DF. Bipolar disorder as maladaptive
arousal: a behavioral model and evidence. Annals of the NY Acad of Science
2008 May; 1129:185-189. 4. Robins CS, Ware NC, dosReis S, Willging CE, Chung
JY, Lewis Fernandez R. Dialogues on mixed-methods and mental health services
research: Anticipating challenges, building solutions. Psychiatric Services
2008 Jul; 59(7): 727-731. 5. Santora PB, Hutton HE. Longitudinal trends in
hospital admissions with co-occurring alcohol/drug diagnoses, 1994-2002.
J Subst Abuse Treat 2008 July;35:1-12. 6. Samuels JF, Bienvenu OJ, Grados MA, Cullen B,
Riddle MA, Liang KY, Eaton WW, Nestadt G. Prevalence and correlates of
hoarding behavior in a community-based sample. Behav Res Ther 2008 Jul;46(7):836-44.
7. Tarazi R, Zabel TA, Mahone EM. Age-related differences
in executive function among children with spina bifida/hydrocephalus based
on parent behavior ratings. The Clinical Neuropsychologist 2008 Jul;22(4):585-602. 8. Wilcox HC, Kellam
SG, Brown CH, Poduska JM, Ialongo NS, Wang W, Anthony JC. 9. Zandi PP, Belmonte PL, Willour VL, Goes FS, Badner
JA, Simpson SG, Gershon ES, 10. Zandi PP, Zöllner S, Avramopoulos
D, Willour VL, Chen Y, Qin ZS, Burmeister M, 1. Anderson EL, Janofsky J, Jayaram G. Argyria as
a result of somatic delusions. Am J Psychiatry 2008 May;165(5):649-50.
2. Blass DM, Black BS, Phillips H, Finucane T, Baker
A, Loreck D, Rabins PV. Medication use in nursing home residents with
advanced dementia. Int J Geriat Psych 2008 May;23(5):490-6. 3. Davydow DS, Desai SV, Needham DM, Bienvenu OJ.
Psychiatric morbidity in survivors of the acute respiratory distress syndrome:
a systematic review. Psychosom Med. 2008 May;70(4):512-9. 4. Duan W, Peng Q, Masuda N, Ford E, Tryggestad
E, Ladenheim B, Zhao M, Cadet JL, Wong J, Ross CA. Sertraline slows disease
progression and increases neurogenesis in N171-82Q mouse model of Huntington's
disease. Neurobiol Dis. 2008 Jun;30(3):312-22. 5. Eaton WW, Shao H, Nestadt G, Lee BH, Bienvenu
OJ, Zandi P. Population-based study of first onset and chronicity in major
depressive disorder. Arch Gen Psychiatry. 2008 May;65(5):513-20. 6. Goes FS, Sanders LL, Potash JB. The genetics
of psychotic bipolar disorder. Curr Psychiatry Rep. 2008 Apr;10(2):178-89.
7. Kaminski BJ, Goodwin, AK, Weerts, EM. Dissociation
of alcohol-seeking and consumption under a chained schedule of oral alcohol
reinforcement in baboons. Alcohol Clin Exp Res. 2008 Jun;32(6):1014-1022.
8. Maust DT, Blass DM, Black BS, Rabins PV. Treatment
decisions regarding hospitalization and surgery for nursing home residents
with advance dementia: The CareAD Study. International Psychogeriatrics,
2008, 20(2):406-418. 9. Masuda N, Peng Q, Li Q, Jiang M, Liang Y, Wang
X, Zhao M, Wang W, Ross CA, Duan W. Tiagabine is neuroprotective in the
N171-82Q and R6/2 mouse models of Huntington's disease. Neurobiol Dis.
2008 Jun;30(3):293-302. 10. Pinto A, Greenberg BD, Grados MA, Bienvenu OJ
3rd, Samuels JF, Murphy DL, Hasler G, Stout RL, Rauch SL, Shugart YY,
Pauls DL, Knowles JA, Fyer AJ, McCracken JT, Piacentini J, Wang Y, Willour
VL, Cullen B, Liang KY, Hoehn-Saric R, Riddle MA, Rasmussen SA, Nestadt
G. Further development of YBOCS dimensions in the OCD Collaborative Genetics
Study: Symptoms vs. categories. Psychiatry Res. 2008 Jul15: 160(1):83-93.
11. Schretlen DJ, Testa SM, Winicki JM, Pearlson
GD, Gordon B. Frequency and bases of abnormal performance by healthy adults
on neuropsychological testing. J Int Neuropsychol Soc. May 2008;14(3):436-445.
12. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis
RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker
PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C,
Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee
KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson
M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH,
Gurling HM, Purcell SM. Collaborators: Marangell LB, Calabrese JR, Nierenberg
AA, Hauser P, Ketter TA, Thomas M, Patel J, Fossey MD, Gyulai L, Thase
ME, Bowden CL, Molay F, Rosen-Sheidley B, Silfies L, Gejman PV, Sanders
AR, Amin F, Buccola N, Byerley W, Cloninger CR, Crowe R, Black D, Freedman
R, Levinson D, Mowry B, Silverman J, Nurnberger J, Miller MJ, Bowman ES,
Rau NL, Moe PR, Samavedy N, El-Mallakh R, Manji H, Glitz DA, Meyer ET,
Smiley C, Foroud T, Flury L, Dick DM, Edenberg H, Rice J, Reich T, Goate
A, Bierut L, McInnis M, DePaulo JR Jr, MacKinnon DF, Mondimore FM, Potash
JB, Zandi PP, Avramopoulos D, Payne J, Berrettini W, Byerley W, Vawter
M, Coryell W, Crowe R, Gershon E, Badner J, McMahon F, Liu C, Sanders
A, Caserta M, Dinwiddie S, Nguyen T, Harakal D, Kelsoe J, McKinney R,
Scheftner W, Kravitz HM, Marta D, Vaughn-Brown A, Bederow L, McMahon FJ,
Kassem L, Detera-Wadleigh S, Austin L, Murphy DL. Whole-genome association
study of bipolar disorder. Mol Psychiatry. 2008 Jun;13(6):558-69. 13.Terracciano A, Löckenhoff CE, Crum RM, Bienvenu
OJ, Costa PT Jr. Five-factor model personality profiles of drug users.
BMC Psychiatry. 2008 Apr 11;8:22. 14. Verma R, Holmans P, Knowles JA, Grover D, Evgrafov
OV, Crowe RR, Scheftner WA, Weissman MM, Depaulo JR Jr, Potash JB, Levinson
DF. Linkage Disequilibrium Mapping of a chromosome 15q25-26 major depression
linkage region and sequencing of NTRK3. Biol Psychiatry. 2008 Jun 15;63(12):1185-9.
15. Yassa MA, Verduzco G, Cristinzio C, Bassett
SS. Altered fMRI activation during mental rotation in those at genetic
risk for Alzheimer's disease. Neurology. 2008 May 13; 70:1898-1904. 1. Blass DM, Black BS, Philips H, Finucane T, Baker
A, Loreck D, Rabins PV. Medication use in nursing home residents with
advanced dementia. International Journal of Geriatric Psychiatry. 2008
May;23(5):490-6. 2. dosReis S, Myers MA. Parental attitudes and involvement
in psychopharmacological treatment for ADHD: a conceptual model. Int Rev
Psychiatry. 2008 Apr;20(2):135-41. 3. dosReis S, Johnson E, Steinwachs D, Rohde C,
Skinner AE, Fahey M, Lehman AF. Antipsychotic treatment patterns and hospitalizations
among adults with schizophrenia. Schizophr Res. 2008 Apr;101(1-3):304-11.
4. Lanier RK, Umbricht A, Harrison JA, Nuwayser
ES, Bigelow GE. Opioid detoxification via single 7-day application of
a buprenorphine transdermal patch: An open-label evaluation. Psychopharmacology
2008 Apr;101(1-3):304-11. 5. Meda SA, Giuliani NR, Calhoun VD, Kanchana J,
Schretlen DJ, Pulver A, Cascella N, Keshavan M, Kates W, Buchanan R, Sharma
T & Pearlson GD. A large scale (N=400) investigation of gray matter
differences in schizophrenia using optimized voxel-based morphometry.
Schizophr Res. Apr 2008;101(1-3):95-105. 6. Payne JL, MacKinnon DF, Mondimore FM, McInnis
MG, Schweizer B, Zamoiski RB,McMahon FJ, Nurnberger JI Jr, Rice JP, Scheftner
W, Coryell W, Berrettini WH, Kelsoe JR, Byerley W, Gershon ES, DePaulo
JR Jr, Potash JB. Familial aggregation of postpartum mood symptoms in
bipolar disorder pedigrees. Bipolar Disord. 2008 Feb;10(1):38-44. 7. Roeder MB, Mahone EM, Gidley Larson J, Mostofsky
SH, Cutting LE, Goldberg MC, Denckla MB. Left-right differences on timed
motor examination in children. Child Neuropsychol. 2008 May;14(3):249-62. 8. Rudnicki, D.D., Pletnikova, O., Vonsattel, J.P.,
Ross, C.A., Margolis, R.L. A Comparison of Huntington Disease and Huntington
Disease-Like 2 Neuropathology. (2008) J Neuropathol Exp Neurol. 67, 366-374. 9. Wachtel LE, Kahng S, Dhossche DM, Cascella N,
Reti IM. ECT for catatonia in an autistic girl. Am J Psychiatry. 2008
Mar;165(3):329-33. 10. Wodka EL, Loftis C, Mostofsky SH, Prahme C,
Larson JC, Denckla MB, Mahone EM. Prediction of ADHD in boys and girls
using the D-KEFS. Arch Clin Neuropsychol. 2008 May;23(3):283-93. 1. dosReis S, Myers MA. Parental attitudes and involvement
in psychopharmacological treatment for ADHD: A conceptual model. International
Review of Psychiatry. 2008 April; 20(2):135-141 2. Harris, K.M, Mahone, E. M., Singer, H.S. Nonautistic
motor stereotypies: clinical features and longitudinal follow-up. Pediatr
Neurol 2008 April; 38(4):267-272. 3. Knealing, TW, Roebuck, MC, Wong, CJ, Silverman,
K. Economic cost of the therapeutic workplace intervention added to methadone
maintenance. J Subst Abuse Treat. 2008 Apr; 34(3):326-32. 4. Liu Z, Wang X, Yu Y, Li X, Wang T, Jiang H, Ren
Q, Jiao Y, Sawa A, Moran T, Ross CA, Montell C, Smith WW. A Drosophila
model for LRRK2-linked parkinsonism. Proc Natl Acad Sci U S A. 2008 Feb
19;105(7):2693-8. 5. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross
CA, Duan W. The antidepressant sertraline improves the phenotype, promotes
neurogenesis and increases BDNF levels in the R6/2 Huntington's disease
mouse model. Exp Neurol. 2008 Mar;210(1):154-63. 6. Payne JL, MacKinnon DF, Mondimore FM, McInnis
MG, Schweizer B, Zamoiski RB, McMahon FJ, Nurnberger JI Jr, Rice JP, Scheftner
W, Coryell W, Berrettini WH, Kelsoe JR, Byerley W, Gershon ES, DePaulo
JR Jr, Potash JB.Familial aggregation of postpartum mood symptoms in bipolar
disorder pedigrees. Bipolar Disorders. 2008 Feb;10(1):38-44. 7. Pletnikov MV, Ayhan Y, Xu Y, Nikolskaia O, Ovanesov
M, Huang H, Mori S, Moran TH, Ross CA. Enlargement of the lateral ventricles
in mutant DISC1 transgenic mice. Mol Psychiatry. 2008 Feb;13(2):115. 8. Stitzer ML, Vandrey R. Contingency management:
Utility in the treatment of drug abuse disorders. Clin Pharmacol Ther
2008 Apr;83(4):644-647. 10. Stitzer ML. Brief interventions for tobacco
cessation. Addiction 2008 Feb;103(2):305-306. 1. Chen J, Scott KA,
Zhao Z, Moran TH, Bi S. Characterization of the feeding inhibition and
neural activation produced by dorsomedial hypothalamic cholecystokinin
administration. Neuroscience. 2008 March; (152) 178-188. 2. McKibben JB, Bresnick
MG, Wiechman Askay SA, Fauerbach JA. Acute stress disorder and posttraumatic
stress disorder: a prospective study of prevalence, course, and predictors
in a sample with major burn injuries. J Burn Care Res. 2008 Jan-Feb; 29(1):22-35. 3. Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein
RC. Effect of depression on late (8 years) mortality after myocardial
infarction. Am J Cardiol. 2008 Mar 1; 101(5):602-6. 4. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross
CA, Duan W. The antidepressant sertraline improves the phenotype, promotes
neurogenesis and increases BDNF levels in the R6/2 Huntington's disease
mouse model. Exp Neurol. 2008 Mar; 210(1):154-63. 5. Thombs BD, Notes LD, Lawrence JW, Magyar-Russell
G, Bresnick MG, Fauerbach JA. From survival to socialization: a longitudinal
study of body image in survivors of severe burn injury. J Psychosom Res.
2008 Feb; 64(2):205-12. 1. Aja S, Landree LE, Kleman AM, Medghalchi SM,
Vadlamudi A, McFadden JM, Aplasca A, Hyun J, Plummer E, Daniels K, Kemm
M, Townsend CA, Thupari JN, Kuhajda FP, Moran TH, Ronnett GV. Pharmacological
stimulation of brain carnitine palmitoyl-transferase-1 decreases food
intake and body weight. Am J Physiol Regul Integr Comp Physiol. 2008 Feb;
294(2):R352-61. 2. Goes FS, Sadler B, Toolan J, Zamoiski RD, Mondimore
FM, Mackinnon DF, Schweizer B; Bipolar Disorder Phenome Group, Raymond
Depaulo J Jr, Potash JB. Psychotic features in bipolar and unipolar depression.
Bipolar Disord. 2007 Dec;9 (8):901-6. 3. Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder
JR, Jasinski DR, Johnson RE, Jones HE, Huestis MA. Buprenorphine and norbuprenorphine
in hair of pregnant women and their infants after controlled buprenorphine
administration. Clinical Chemistry 2007 Dec; 53 (12): 2136-2143. 4. Nestadt G, Costa PT Jr, Hsu FC, Samuels J, Bienvenu
OJ, Eaton WW. The relationship between the five-factor model and latent
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
personality disorder dimensions. Compr Psychiatry. 2008 Jan-Feb; 49(1):98-105.
5. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov
MV, Huang H, Mori S, Moran TH, Ross CA. Inducible expression of mutant
human DISC1 in mice is associated with brain and behavioral abnormalities
reminiscent of schizophrenia. Mol Psychiatry. 2008 Feb;13(2):173-86. 7. Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS,
Frost JJ, McCaul M E. Differences in delta- and mu-opioid receptor blockade
measured by PET in naltrexone-treated recently abstinent alcohol-dependent
subjects. Neuropsychopharmacology 2008 Feb; 33(3): 653-665. 8. Yasumoto F, Hayashi A, Kamiya A, Negishi T, Yoshikawa
Y, Sawa A. Genetic manipulation of brain cultures from the primates: a
novel tool for molecular studies of neuropsychiatric disorders. Mol Psychiatry.
2008 Feb;13(2):116-118. 1. Black BS, Brandt J,
Rabins PV, Samus QM, Steele CD, Lyketsos CG, Rosenblatt A. Predictors
of providing informed consent or assent for research participation in
assisted living residents. American Journal of Geriatric Psychiatry, 2008
January;16(1):83-91. 2. Easterbrook JD, Kaplan JB, Glass GE, Pletnikov
MV, Klein SL. Elevated testosterone and reduced 5-HIAA concentrations
are associated with wounding and hantavirus infection in male Norway rats.
Horm Behav. 2007 Nov;52(4):474-81. 3. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey
R, Brasic J, Ye W, Alexander 4. McKibben J, Bresnick MG, Askay Wiechman SA, Fauerbach
JA. Acute stress disorder and posttraumatic stress disorder: A prospective
study of prevalence, course and predictors with major sample major burn
injuries. J. Burn Care Research. 2008 January/February;29(1):22-35. 5. Potash JB, Buervenich S, Cox NJ, Zandi PP, Akula
N, Steele J, Rathe JA, Avramopolous D, Detera-Wadleigh SD, Gershon ES,
Depaulo JR Jr, Feinberg AP, McMahon FJ, NIMH Genetics Initiaive Bipolar
Disorder Consortium. Gene-based SNP mapping of a psychotic bipolar affective
disorder linkage region on 22q12.3: Association with HMG2L1 and TOM1.
Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147(1):59-67 6. Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney
MC. QT-interval effects of methadone, levomethadyl, and buprenorphine
in a randomized trial. Arch Intern Med. 2007 Dec 10;167(22):2469-75. 7. Winstanley EL, Steinwachs DM, Ensminger
ME, Latkin CA, Stitzer ML, Olsen Y. 1. Carroll CP, Kidorf
M, Strain EC, Brooner RK. Comparison of demographic and clinical characteristics
between opioid-dependent individuals admitted to a community-based treatment
setting and those enrolled in a research-based treatment setting. J Subst
Abuse Treat. 2007 Dec;33(4):355-361. 2. de Lateur BJ, Magyar-Russell G, Bresnick MG,
Bernier FA, Ober MS, Krabak BJ, Ware L, Hayes MP, Fauerbach JA. Augmented
exercise in the treatment of deconditioning from major burn injury. Arch
Phys Med Rehabil. 2007 Dec;88(12 Suppl 2):S18-23. 3. Edwards RR, Magyar-Russell G, Thombs B, Smith
MT, Holavanahalli RK, Patterson DR, Blakeney P, Lezotte DC, Haythornthwaite
JA, Fauerbach JA. Acute pain at discharge from hospitalization is a prospective
predictor of long-term suicidal ideation after burn injury. Arch Phys
Med Rehabil. 2007 Dec;88(12 Suppl 2):S36-42. 4. Esselman PC, Askay SW, Carrougher GJ, Lezotte
DC, Holavanahalli RK, Magyar-Russell G, Fauerbach JA, Engrav LH. Barriers
to return to work after burn injuries. Arch Phys Med Rehabil. 2007 Dec;88(12
Suppl 2):S50-6. 5. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken
RH, Webster MJ, Dinkins T,Callinan PA, Fan JB, Potash JB, Feinberg AP.
DNA methylation signatures within the human brain. Am J Hum Genet. 2007
Dec;81(6):1304-15. 6. Lezotte DC, Hills RA, Heltshe SL, Holavanahalli
RK, Fauerbach JA, Blakeney P, Klein MB, Engrav LH. Assets and liabilities
of the Burn Model System data model: a comparison with the National Burn
Registry. Arch Phys Med Rehabil. 2007 Dec;88(12 Suppl 2):S7-17. 7. Lofwall MR, Walsh SL, Bigelow GE, Strain EC.
Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
Psychopharmacology 2007 Oct;194(3):381-93. 8. McCann UD, Ricaurte GA. Effects of (+/-) 3,4
-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms.
ScientificWorldJournal 2007 Nov;7:231-8. 9. Schroeder M, Lavi-Avnon Y, Zagoory-Sharon O,
Weller A, Moran TH. Preobesity in the infant OLETF rat: The role of suckling.
Dev Psychobiol. 2007 Nov;49(7):685-91. 10. Stitzer ML, Petry N, Peirce J, Kirby K, Killeen
T, Roll J, Hamilton J, Stabile PO, Sterling R, Brown C, Kolodner K, Li
R. Effectiveness of abstinence-based incentives: Interaction with intake
stimulant test results. J Consult Clin Psychol 2007 Oct;75(5):805-11. 11. Verma R, Cutler DJ, HolmansP, Knowles JA, Crowe
RR, Scheftner WA, Weissman MM, DePaulo JR Jr, Levinson Df, Potash JB.
Investigating the role of p11 (S100A10) sequence variation in susceptibility
to major depression. Am J Med Genet B Neuropsychiatr Genet. 2007 May 17 1. Bienvenu OJ, Hettema JM, Neale MC, Prescott CA,
Kendler KS. Low extraversion and high neuroticism as indices of genetic
and environmental risk for social phobia, agoraphobia,
and animal phobia. Am J Psychiatry. 2007 Nov;164(11):1714-21. 2. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly
S, Strynadka K, Chohnan S, Smith WW, Tamashiro KL, Ladenheim EE, Ronnett
GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH. Leptin activates hypothalamic
acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci U S
A. 2007 Oct 30;104(44):17358-63. 3. Hamshere ML, Holmans PA, Avramopoulous D, Bassett
SS, Blacker D, Bertram L, 4. Lanier RK, Umbricht A, Harrison JA, Nuwayser
ES, Bigelow GE. Evaluation of a transdermal buprenorphine formulation
in opioid detoxification. Addiction 2007 Oct;102(10):1648-56. 5. Pucak ML, Carroll KA, Kaplin AI, Kerr DA Neuropsychiatric
manifestations of depression in multiple sclerosis: neuroinflammatory,
neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated
depression. Dialogues in Clinical Neuroscience, 2007; 9(2): 125-39. 6. Rosado J, Walsh SL, Bigelow GE, Strain EC. Sublingual
buprenorphine/naloxone precipitated withdrawal in subjects maintained
on 100mg of daily methadone. Drug Alcohol Depend 2007 Oct;90(2-3):261-9. 7. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut
M, Pearlson GD, Gordon B, Jinnah HA. Serum uric acid and brain ischemia
in normal elderly adults. Neurology. 2007 Oct 2;69(14):1418-1423. 8. Silverman K, Wong CJ, Needham M, Diemer KN, Knealing
T, Crone-Todd D, Fingerhood M, Nuzzo P, Kolodner K A randomized trial
of employment-based reinforcement of cocaine abstinence in injection drug
users. J Appl Behav Anal. 2007;40:387-410. 1. Nwulia EA, Miao K, Zandi PP, Mackinnon DF, DePaulo
JR Jr, McInnis MG. Genome-wide scan of bipolar II disorder. Bipolar Disord
2007 Sep;9(6):580-8. 2. Payne JL. Antidepressant use in the postpartum
period: practical considerations. Am J Psychiatry. 2007 Sep;164(9):1329-32. 3. Potash JB, Toolan J, Steele J, Miller EB, Pearl
J, Sandi PP, Schultze TG, Kassem L, Simpson SG, Lopez V, NIMH Genetics
Initiative Bipolar Disorder Consortium, MacKinnon DF, McMahon FJ. The
bipolar disorder phenome database: a resource for genetic studies. Am
J Psychiatry. 2007 Aug;164(8):1229-37. 1. Black BS, Kass NE, Fogarty LA, Rabins PV. Informed
consent for dementia research: The study enrollment encounter. IRB: Ethics
& Human Research 2007, 29(4):7-14. 2. Cascella NG, Takaki M, Lin S, Sawa A. Neurodevelopmental
involvement in schizophrenia: the olfactory epithelium as an alternative
model for research. J Neurochem 2007 Aug;102(3):587-94. 3. Colomer Gould VF, Goti D, Pearce D, Gonzalez
G, Gao H, Bermudez de Leon M, Jenkins NA, Copeland N, Ross CA, and Brown
DR. A mutant ataxin-3 fragment results from processing at a site N-terminal
to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
Neurobiology of Disease 2007; 27: 362-9. 4. Fagan PJ. Sex therapy and research: a view from
health services research. Journal of Sex and Marital Therapy. 2007: 33:5,
427 -432. 5. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K,
Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher
M, Ishizuka K, Pletnikov M, Kida S, Sawa A. From the Cover: Dominant-negative
DISC1 transgenic mice display schizophrenia-associated phenotypes detected
by measures translatable to humans. Proc Natl Acad Sci U S A 2007 Sep;104(36):14501-6. 6. Matsuzawa D, Hashimoto K, Miyatake R, Shirayama
Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, Ozaki N,
Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Hata A, Sawa
A, Iyo M. Identification of functional polymorphisms in the promoter region
of the human PICK1 Gene and their association with methamphetamine psychosis.
Am J Psychiatry 2007 Jul;164(7):1105-14. 7. Potash JB, Toolan J, Steele J, Miller EB, Pearl
J, Zandi PP, Schulze TG, Kassem L, Simpson SG, Lopez V. NIMH Genetics
Initiative Bipolar Disorder Consortium, MacKinnon DF, McMahon FJ. The
bipolar disorder phenome database: a resource for genetic studies. Am
J Psychiatry. 2007 Aug;164(8):1229-37. 8. Schretlen DJ, Cascella NG, Meyer SM, Kingery
LR, Testa SM, Munro CA, Pulver AE, 9. Scott KA, Moran TH. The GLP-1 agonist exendin-4
reduces food intake in nonhuman primates through changes in meal size.
Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R983-987. 10. Sindelar JL, Olmstead TA, Peirce JM. Cost-effectiveness
of prize-based contingency management in methadone maintenance treatment
programs. Addiction 2007 Sept; 102 (9): 1463-1471. 11. Stitzer ML, Peirce J, Petry N, Kirby K, Roll
J, Krasnansky J, Cohen A, Blaine J, Vandrey R, Kolodner K, Li R. Abstinence-based
incentives in methadone maintenance: Interaction with intake stimulant
test results. Experimental and Clinical Psychopharmacology; 2007 Aug;15(4):344-50. 12. Subramaniam, GA, Stitzer MA, Clemmey P, Kolodner,
K, Fishman, MJ. Baseline depressive symptoms predict poor substance use
outcome following adolescent residential treatment. 13. Weerts EM, Fantegrossi WE, Goodwin AK. The value
of nonhuman primates in drug abuse research. Exp Clin Psychopharmacol.
2007 Aug;15(4):309-27. 14. Weerts EM, Froestl W, Kaminski BJ, Griffiths
RR. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen
and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons.
Drug Alcohol Depend. 2007 Jul 10;89(2-3):206-13. Epub 2007 Jan 16. 1. Grover D, Woodfield
AS, Verma R, Zandi PP, Levinson DF, Potash JB. Quick SNP: an automated
web server for selection of tagSNPs. Nucleic Acids Res.2007 July 1:35
(Web Server issue)W115-20 2. Kalaydijan A, Eaton W, Zandi P. Migraine headaches
are not associated with a unique depressive symptom profile: Results from
the Baltimore Epidemiologic Catchment Area Study. J Psychosomatic Res
2007 Aug 63(2):123-9. 3. Lofwall MR, Walsh SL, Bigelow GE, Strain EC,
Experimentally-induced spontaneous opiate withdrawal: relationship to
cigarette craving and expired air carbon monoxide. Am J Addict. 2007 Jul-Aug;16(4):310-5. 4. Mondimore FM, Zandi PP, MackinnonDF, McInnis
MG, Miller EB. Schweizer B, Crowe RP, Scheftner WA, Weissman MN, Levinson
DF, DePaulo JR Jr, Potash JB. A comparison of the famiality of chronic
depression in recurrent early onset depression pedigrees using different
definitions of chronicity. J Affective Disorders 2007 June: 100(1-3):171-7.
5. Pletnikov MV, Xu Y, Ovanesov MV, Kamiya A, Sawa
A, Ross CA. PC12 cell model of inducible expression of mutant DISC1: New
evidence for a dominant-negative mechanism of abnormal neuronal differentiation.
Neurosci Res. 2007 Jul;58(3):234-44. 6. Swartz KL, KastelicEA, Hess SG, Cox TS,
Gonzales LC, Mink SP, DePaulo JR Jr. The effectiveness of a school-based
adolescent depression education program. Health Education Behavior 2007
July 25 [Epub ahead of print]. 1. Bi S, Chen J, Behles RR, Hyun J, Kopin AS, Moran
TH. D ifferential body weight and feeding responses
to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. 2. Fauerbach JA, McKibben J, Bienvenu OJ, Magyar-Russell
G, Smith MT, Holavanahalli 3. Matsuzawa D, Hashimoto K, Miyatake R, Shirayama
Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, Ozaki N,
Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Hata A, Sawa
A, Iyo M. Identification of functional polymorphisms in the promoter region
of the human PICK1 gene and their association with methamphetamine psychosis.
Am J Psychiatry 2007 Jul;164(7):1105-14 |
